Ronovo Surgical, a Shanghai, China-based robotic and digital surgery space company, raised $50M+ in funding.
The round was led by LongRiver Investments, with participation from Lilly Asia Ventures, Vivo Capital, Matrix Partners China, and GGV Capital.
The company intends to use the funds to accelerate the multi-discipline clinical trial for Carina, strengthen R&D and clinical applications development, and further bolster its talent base.
Co-Founded by John Ma (CEO) and Ying Mao (CTO), Ronovo Surgical is accelerating the transition to intelligent minimally invasive surgeries through innovative robotic and digital solutions. Exiting stealth mode, Ronovo launched its inaugural robotic platform – Carina™, an innovative modular system built on proprietary technology to enable configurable robotic assistance for laparoscopic surgeries across multiple specialties.
While Carina was developed with Chinese laparoscopic surgeons as the use case, early discussions with robotic surgery KOLs in US and Europe indicate the system’s potential to overcome current barriers of broad RAS adoptions in many international markets. Ronovo plans to continue discussions with clinical KOLs, strategic partners and global investors at upcoming conferences worldwide, including the LSI Emerging Medtech Summit, MedTech Strategist Innovation Summit, and Society of Robotic & Digital Surgery.
FinSMEs
01/02/2023